Login To Trade  |  About IIFL
  • NIFTY  7215.7  -82.5 -1.13%
  • SENSEX 23758.9  -262.08 -1.09%
  1. General
  2. Others

  3. Others

Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai | November 08, 2012 12:51 IST

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs — Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 538.85 [17.65] ([3.17]%)
NSE 538.60 [17.25] ([3.10]%)

***Note: This is a NSE Chart


Get the most detailed result analysis on the web - Real Fast!

Actionable & Award-Winning Research on 500 Listed Indian Companies.

Read more on: Cipla   
article
113110704863
Cipla cuts prices on 3 anti-cancer drugs: reports
Cipla cuts prices on 3 anti-cancer drugs: reports
Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.
http://www.indiainfoline.com/article/news-top-story/cipla-cuts-prices-on-3-anti-cancer-drugs-reports-113110704863_1.html
November 08, 2012 12:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Cipla
Others
$rawVideoFileUrl$
$videoPlayerUrl$

Download IIFL Markets App